KP

Karl Pfleger

North America, California, United States, San Francisco

Description

Karl Pfleger

Investor Profile

Karl Pfleger has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Biopharma.

Stage Focus

  • Seed (50%)
  • Series A (50%)

Country Focus

  • United States (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Karl Pfleger frequently co-invest with?

Infinita Fund
North America, Islas de la Bahia, Honduras, Roatán
Co-Investments: 1
Emerging Longevity Ventures
North America, Florida, United States, West Palm Beach
Co-Investments: 1
VitaDAO
North America, Ontario, Canada, Ottawa
Co-Investments: 1
Healthspan Capital
North America, California, United States, El Cerrito
Co-Investments: 1
Compound
North America, New York, United States, New York
Co-Investments: 1
Felicis
North America, California, United States, Menlo Park
Co-Investments: 1
Horizons Ventures
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
BoxOne Ventures
North America, Quebec, Canada, Montréal
Co-Investments: 1
1517 Fund
North America, California, United States, Oakland
Co-Investments: 1
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 1

Which angels does Karl Pfleger often collaborate with?

Balaji Srinivasan
Asia, Central Region, Singapore, Singapore
Shared Deals: 1
JD
North America, California, United States, Palo Alto
Shared Deals: 1
TE
North America, Massachusetts, United States, Boston
Shared Deals: 1
Shared Deals: 1
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Karl Pfleger?

ImmuneAGE Bio is a drug discovery platform focused on rejuvenating the immune system.

BiotechnologyHealth Care
SeedJul 12, 2024
Amount Raised: $2,000,000
Juvena Therapeutics

Palo Alto, California, United States

Juvena Therapeutics is a biopharmaceutical platform which is discovering novel protein-based therapeutics.

BiopharmaBiotechnologyHealth Care
Series ANov 8, 2022
Amount Raised: $41,000,000